Seattle, WA, United States of America

Stacey R Dillon

USPTO Granted Patents = 43 

 

 

Average Co-Inventor Count = 7.1

ph-index = 10

Forward Citations = 480(Granted Patents)


Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
43 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Stacey R. Dillon and His Contributions to Immunology

Introduction: Stacey R. Dillon is a prominent inventor based in Seattle, WA, with an impressive portfolio of 42 patents. His work primarily focuses on immunomodulatory proteins, which hold significant potential for therapeutic applications in various immunological diseases and conditions. Dillon's research has greatly contributed to the advancement of immunology, exhibiting innovative approaches in the field.

Latest Patents: Among Stacey R. Dillon's latest patents is a groundbreaking invention relating to APRIL and BAFF inhibitory immunomodulatory proteins. This patent provides detailed descriptions of proteins that demonstrate neutralizing activity against BAFF and APRIL, including BAFF/APRIL heterotrimers. The immunomodulatory proteins encompass variant domains of the Transmembrane Activator and CAML Interactor (TACI), specifically highlighting TACI-Fc fusion proteins. Additionally, the patent includes nucleic acid molecules encoding these proteins and outlines their therapeutic utility for various immunological diseases, disorders, or conditions. It further elaborates on the compositions and methods for creating and utilizing these proteins in medical treatments.

Career Highlights: Throughout his career, Stacey R. Dillon has had notable experiences at renowned institutions including Zymogenetics, Inc. and the University of Washington. His work in these organizations has allowed him to push the boundaries of research in immunology, leading to significant advancements and valuable intellectual property.

Collaborations: Collaboration is key to innovation, and Dillon has worked alongside esteemed colleagues such as Jane A. Gross and Julia E. Novak. Together, these professionals have contributed to crucial research initiatives that focus on the enhancement of immunological therapies, reinforcing the importance of teamwork in scientific discovery.

Conclusion: Stacey R. Dillon's impressive track record of patents and collaborations underscores his standing as a leading inventor in the field of immunology. His innovative contributions, particularly in the realm of immunomodulatory proteins, continue to pave the way for exciting advancements in medical treatments for immunological diseases. The impact of his work is felt not only in scientific circles but also in the lives of individuals benefiting from these therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…